During the past decade, Arnas Ospedale Civico; Medicina Interna II conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Arnas Ospedale Civico; Medicina Interna II" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Arnas Ospedale Civico; Medicina Interna II" in a lesser frequency.

Most popular intervention types in "Arnas Ospedale Civico; Medicina Interna II" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DMARDs" (1 trials), "Standard DMARDs (Disease Modifying Anti Rheumatic Drugs)" (1 trials), "Tocilizumab" (1 trials) and "tocilizumab [RoActemra/Actemra]" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arnas Ospedale Civico; Medicina Interna II" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Arnas Ospedale Civico; Medicina Interna II". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Arnas Ospedale Civico; Medicina Interna II, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arnas Ospedale Civico; Medicina Interna II, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".